NYMXF
NYMOX PHARMACEUTICAL CORP
$0.0970
+1.36%
No data for this timeframe.
Vol
SEC Reports2
Recent Activity
Jun 3, 2026
SEC
Nymox Pharmaceutical provided an update on its drug Nymozarfex (TM) for BPH. The initial US submission was not accepted
6-K — Impact 6/10
Jun 1, 2026
earnings_calendar
NYMXF Q4 2025 Earnings Scheduled — 2026-06-01
Mar 27, 2026
SEC
Nymox Pharmaceutical announced board changes, including the retirement of Patrick Doody and the passing of Co-Chairman J
6-K — Impact 4/10
Latest Reports
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
2 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 1 neutral. Avg impact: 5.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Jun 1, 2026
earnings_calendar
NYMXF Q4 2025 Earnings Scheduled — 2026-06-01